iCo Therapeutics Engages Ora for iCo-008 Ophthalmic Strategy and Pre Phase II FDA Meeting News December, 2019 Ora and SDC Congratulate ProQR on Positive Topline Results News October, 2019 Ora and SDC Congratulate Nicox on Phase II Glaucoma Trial Topline Results News October, 2019 Retina Global Reception at AAO 2019 News September, 2019 Spotlight on Blepharitis Articles September, 2019 Ora®, Inc. has been retained by ProQR Therapeutics to provide mobility test services using the Ora-VNC™ for the QR-110 development program for Leber’s Congenital Amaurosis Type 10 News November, 2018 Will the Evolving Economic Landscape for Dry Eye Products Impact Investment? Articles October, 2018 Keith Lane Discussing Ora’s Standardized Mobility Course (Ora-VNC™) Articles October, 2018 Presbyopia Therapies Announces Primary Safety and Efficacy Endpoints met in a Phase IIb study of its Topical PRX Ophthalmic Solution for the Treatment of Presbyopia Articles June, 2018 Ora, Inc. Unifies its Clinical Environment with Veeva to Accelerate Trial Execution News March, 2018 1 2 … 6 »
